These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26948313)

  • 1. Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: Pitfalls, promises and what lies ahead?
    Prasanna G; Li B; Mogi M; Rice DS
    Eur J Pharmacol; 2016 Sep; 787():47-56. PubMed ID: 26948313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylate cyclase activators, cell volume changes and IOP reduction.
    Ellis DZ
    Cell Physiol Biochem; 2011; 28(6):1145-54. PubMed ID: 22179003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.
    Rao PV; Pattabiraman PP; Kopczynski C
    Exp Eye Res; 2017 May; 158():23-32. PubMed ID: 27593914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide (NO): an emerging target for the treatment of glaucoma.
    Cavet ME; Vittitow JL; Impagnatiello F; Ongini E; Bastia E
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(8):5005-15. PubMed ID: 25125670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.
    Honjo M; Tanihara H
    Jpn J Ophthalmol; 2018 Mar; 62(2):109-126. PubMed ID: 29445943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microstructure visualization of conventional outflow pathway and finite element modeling analysis of trabecular meshwork.
    Zhang J; Ren L; Mei X; Xu Q; Zheng W; Liu Z
    Biomed Eng Online; 2016 Dec; 15(Suppl 2):162. PubMed ID: 28155681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC Constructs.
    Bastia E; Toris CB; Brambilla S; Galli C; Almirante N; Bergamini MVW; Masini E; Sgambellone S; Unser AM; Ahmed F; Torrejon KY; Navratil T; Impagnatiello F
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):17. PubMed ID: 33704360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vital role for nitric oxide in intraocular pressure homeostasis.
    Reina-Torres E; De Ieso ML; Pasquale LR; Madekurozwa M; van Batenburg-Sherwood J; Overby DR; Stamer WD
    Prog Retin Eye Res; 2021 Jul; 83():100922. PubMed ID: 33253900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Trabecular Meshwork Width and Schlemm's Canal Area on Intraocular Pressure Reduction in Glaucoma Patients.
    Chung HW; Park JH; Yoo C; Kim YY
    Korean J Ophthalmol; 2021 Aug; 35(4):311-317. PubMed ID: 34162183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Novel Intraocular-Pressure-Lowering Therapy Targeting ATX.
    Nagano N; Honjo M; Kawaguchi M; Nishimasu H; Nureki O; Kano K; Aoki J; Komatsu T; Okabe T; Kojima H; Nagano T; Aihara M
    Biol Pharm Bull; 2019; 42(11):1926-1935. PubMed ID: 31685776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure.
    Li G; Nottebaum AF; Brigell M; Navarro ID; Ipe U; Mishra S; Gomez-Caraballo M; Schmitt H; Soldo B; Pakola S; Withers B; Peters KG; Vestweber D; Stamer WD
    Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):12. PubMed ID: 33315051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.
    Rao PV
    J Ocul Pharmacol Ther; 2014; 30(2-3):181-90. PubMed ID: 24283588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-associated kinase inhibitors: a novel glaucoma therapy.
    Inoue T; Tanihara H
    Prog Retin Eye Res; 2013 Nov; 37():1-12. PubMed ID: 23770081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of digital ocular massage on intraocular pressure and Schlemm's canal dimensions.
    Wu THY; Lau HKC; Lai CHY; Wong RWL; Wong AKW; Lam AK
    Sci Rep; 2024 Mar; 14(1):6112. PubMed ID: 38480777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations.
    Andrés-Guerrero V; García-Feijoo J; Konstas AG
    Adv Ther; 2017 May; 34(5):1049-1069. PubMed ID: 28349508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trabecular meshwork as a new target for the treatment of glaucoma.
    Ferrer E
    Drug News Perspect; 2006 Apr; 19(3):151-8. PubMed ID: 16804567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway.
    O'Callaghan J; Cassidy PS; Humphries P
    Expert Opin Ther Targets; 2017 Nov; 21(11):1037-1050. PubMed ID: 28952395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma.
    Inoue T; Tanihara H
    Expert Opin Pharmacother; 2017 Oct; 18(15):1669-1673. PubMed ID: 28893104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular Pressure-Lowering Activity of NCX 470, a Novel Nitric Oxide-Donating Bimatoprost in Preclinical Models.
    Impagnatiello F; Toris CB; Batugo M; Prasanna G; Borghi V; Bastia E; Ongini E; Krauss AH
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6558-64. PubMed ID: 26457541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes.
    Li G; Mukherjee D; Navarro I; Ashpole NE; Sherwood JM; Chang J; Overby DR; Yuan F; Gonzalez P; Kopczynski CC; Farsiu S; Stamer WD
    Eur J Pharmacol; 2016 Sep; 787():20-31. PubMed ID: 27085895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.